Results 91 to 100 of about 22,517 (214)

Octreotide [PDF]

Journal of Pain and Symptom Management, 2010
Eva, Murphy, Eric E, Prommer, Mary, Mihalyo, Andrew, Wilcock   +3 more
openaire   +2 more sources

Short-term preoperative octreotide treatment for TSH-secreting pituitary adenoma.

Endocrine journal, 2015
Preoperative control of hyperthyroidism in patients with TSH-secreting pituitary adenomas (TSHoma) may avoid perioperative thyroid storm. Perioperative administration of octreotide may control hyperthyroidism, as well as shrink tumor size. The effects of
Noriaki Fukuhara, K. Horiguchi, H. Nishioka, Hisanori Suzuki, A. Takeshita, Y. Takeuchi, N. Inoshita, S. Yamada   +7 more
semanticscholar   +1 more source

‘Doppler waveform study as indicator of change of portal pressure after administration of octreotide’ [PDF]

, 1969
Shahbaz Haider
openalex   +1 more source

The Effects of Octreotide on Basal and Stimulated Hormone Levels in Patients with Carcinoid Syndrome* [PDF]

, 1989
Kjell Öberg, Ingrid Norheim, Elvar Theodorsson, H. Ahlman, G. Lundqvist, Leif Wide   +5 more
openalex   +1 more source

Hold that needle: Octreotide for acute variceal hemorrhage [PDF]

, 1994
William N. Katkov
openalex   +1 more source

Clinical benefits of above-standard dose of octreotide LAR in patients with neuroendocrine tumors for control of carcinoid syndrome symptoms: a multicenter retrospective chart review study.

The Oncologist, 2014
BACKGROUND Octreotide LAR is used in patients for control of carcinoid syndrome (CS) and other symptoms of hormone hypersecretion. The aim of this study was to examine reasons for octreotide LAR dose escalation and observe CS symptom improvement in ...
J. Strosberg, A. Benson, L. Huynh, M. Duh, J. Goldman, V. Sahai, A. Rademaker, M. Kulke   +7 more
semanticscholar   +1 more source

Randomized controlled study of the effect of octreotide on pancreatic exocrine secretion and pancreatic fistula after pancreatoduodenectomy

Asian Journal of Surgery, 2019
Summary: Background: Octreotide is known to decrease the rate of postoperative complication after pancreatic resection by diminishing exocrine function of the pancreas.
Dong Do You, Kwang Yeol Paik, Il Young Park, Young Kyung Yoo   +3 more
doaj  

Comparative analysis of adverse event profiles of lanreotide and octreotide in somatostatin-responsive endocrine and neoplastic diseases

Scientific Reports
Lanreotide and Octreotide are used to treat various endocrine and neoplastic diseases. This study aims to compare the adverse event profiles of Lanreotide and Octreotide in somatostatin-responsive diseases using FAERS data.
Le Wang, Shenglin Chen, Mengying Wu, Lijuan Zhou   +3 more
doaj   +1 more source

18F-AlF-NOTA-octreotide PET/CT and 3D printing technology for precision diagnosis and treatment of phosphaturic mesenchymal tumors in patients with tumor-induced osteomalacia: two case reports

Frontiers in Endocrinology
ObjectiveThis study aims to report the application of 18F-AlF-NOTA-Octreotide PET/CT and 3D printing technology in the diagnosis and treatment of phosphaturic mesenchymal tumors (PMT) in patients with tumor-induced osteomalacia (TIO).Case presentationA ...
Gang Zhao, Lijuan Guan, Yongqiang Zhang, Xingzhen Shi, Wenming Luo, Maiqing Yang, Qi Wang, Zhen Liu, Yongqiang Liu, Xiaolei Ding, Jie Zhao   +10 more
doaj   +1 more source

Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test [PDF]

, 1994
Dee Pei, C. N. O. Jones, Raag Bhargava, Y. -D. I. Chen, Gerald M. Reaven   +4 more
openalex   +1 more source